Egal Pads
Series A in 2025
Egal Pads designs and manufactures individually wrapped sanitary pads on rolls intended for use in standard toilet paper dispensers in public restrooms. The product enables privacy, ease of use, and convenience for people managing menstrual periods in public stalls, addressing uncertainty and improving access to period care in shared spaces.
Wavely Diagnostics
Seed Round in 2023
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
Kubik is an environmental technology company that constructs low-carbon, durable, and affordable buildings using recycled plastic waste as its primary construction material. The company focuses on creating sustainable residential, commercial, and public facilities.
Integrated Reality Labs
Pre Seed Round in 2023
Integrated Reality Labs (IRL Inc.) specializes in developing integrated reality (IR) games and tools that enhance real-world play. Their patent-pending Integrated Reality Technology Platform uses Ultra-Wideband, Bluetooth, mobile location services, and other device sensors to power products like SLAP, a mobile app that transforms classic games like Assassin, HvZ, and Tag into more engaging and accessible experiences. IRL Inc. aims to empower users to create, share, and monetize their own mobile-powered real-world games, similar to the user-generated content model of Roblox.
Massive Bio
Seed Round in 2020
Massive Bio is an AI-powered platform and advisory services company that connects cancer patients and their oncologists with diagnostic and treatment options, including access to clinical trials. It operates a dual platform strategy: a B2C on-demand service for patients and their oncologists offering testing guidance, treatment recommendations, trial information, and reimbursement support; and a B2B enterprise platform for hospitals and insurers to streamline oncology decision-making. The company features the MB-POA Personalized Oncology Advisor to help integrate cancer genomics, targeted therapies, and outcomes tracking into daily practice. It combines healthcare informatics, oncology expertise, patient identification, pre-screening, and concierge enrollment to address enrollment bottlenecks, facilitating faster trial matching and access to therapies, while compiling real-world data to support drug development and care decisions.
Well Traveled
Angel Round in 2020
Well Traveled operates a members-only travel platform and club that offers trusted recommendations, exclusive perks, and tools for travel discovery, planning, and booking. It enables travelers to connect with local communities and participate in a private membership where insider travel information is shared and trips are planned collaboratively. The platform also helps users find suitable accommodations and access tailored travel services to create memorable experiences.
HUE.AI is an AI-driven design company serving the optical and medical industries. Through its parent Cyborg Industries, it leverages machine learning with chemistry, optics, and materials science to optimize human visual acuity and color perception. Its MAIDAS software is presented as an AI system for evaluating optical performance and cosmetic appeal across lenses, coatings, intraocular lenses, and contacts. The company offers multiple products aimed at eyewear and vision applications, including color vision correction lenses, blue-light blocking lenses, and progressive lenses. HUE.AI positions itself as enabling eyewear manufacturers and optical product designers to innovate, improve performance, and shorten development cycles by integrating AI into lens design and vision-related products.
QSM Diagnostics
Seed Round in 2018
QSM Diagnostics develops point-of-care diagnostics for identifying bacterial infections, with a focus on veterinary applications. The company specializes in electrochemical sensors and disposable sensor-based devices that rapidly detect target bacteria at infection sites, such as ear infections caused by Pseudomonas aeruginosa in dogs. Founded in 2014 as a Northeastern University spin-out, QSM Diagnostics brings together extensive experience in sensor development and medical device commercialization to provide practical diagnostic solutions for animal care.